دسترسی نامحدود
برای کاربرانی که ثبت نام کرده اند
برای ارتباط با ما می توانید از طریق شماره موبایل زیر از طریق تماس و پیامک با ما در ارتباط باشید
در صورت عدم پاسخ گویی از طریق پیامک با پشتیبان در ارتباط باشید
برای کاربرانی که ثبت نام کرده اند
درصورت عدم همخوانی توضیحات با کتاب
از ساعت 7 صبح تا 10 شب
ویرایش: 1 نویسندگان: Francis P. Worden MD (editor), Rami N. Khoriaty MD (editor), Kathleen A. Cooney MD (editor), Michael Deininger MD PhD (editor) سری: ISBN (شابک) : 0826137822, 9780826137821 ناشر: Demos Medical سال نشر: 2018 تعداد صفحات: 420 زبان: English فرمت فایل : PDF (درصورت درخواست کاربر به PDF، EPUB یا AZW3 تبدیل می شود) حجم فایل: 3 مگابایت
در صورت تبدیل فایل کتاب Hematology Board Review: Blueprint Study Guide and Q&A (Book + Free App) به فرمت های PDF، EPUB، AZW3، MOBI و یا DJVU می توانید به پشتیبان اطلاع دهید تا فایل مورد نظر را تبدیل نمایند.
توجه داشته باشید کتاب بررسی هیئت هماتولوژی: راهنمای مطالعه طرح و پرسش و پاسخ (کتاب + برنامه رایگان) نسخه زبان اصلی می باشد و کتاب ترجمه شده به فارسی نمی باشد. وبسایت اینترنشنال لایبرری ارائه دهنده کتاب های زبان اصلی می باشد و هیچ گونه کتاب ترجمه شده یا نوشته شده به فارسی را ارائه نمی دهد.
بررسی هیئت هماتولوژی: راهنمای مطالعه طرح و پرسش
Hematology Board Review: Blueprint Study Guide and Q&A is a concise, outline-based study guide covering all topics that appear on the Hematology Certification Exam. The book includes all topics listed in the American Board of Internal Medicine (ABIM) blueprint as essential material for the exam and highlights topic areas that are often found on the test.
For hematology and oncology fellows as well as practicing clinicians needing a refresher before taking MOC, this handy study guide provides succinct overviews of all blood disorders, syndromes and diseases with practice questions on the go. Each disorder or disease-based chapter provides the same structure for ease of use beginning with the epidemiology, and followed by the etiology and risk factors, signs and symptoms, diagnostic criteria, indications for treatment, prognostic factors, treatment recommendations, and special considerations. The authors provide the most accurate and up-to-date information, including well-established treatment regimens for a variety of blood disorders, including iron disorders, bone marrow failure syndromes, platelet and megakaryocytic disorders, hemostasis, thrombosis, and hematologic malignancies. Later chapters review other major subspecialty areas found on the exam including transfusion medicine and hematopoietic cell transplantation. With 200 board-style questions and answers with detailed rationales, Hematology Board Review is the go-to, quick review for any trainee preparing for initial certification and for hematologists or oncologists preparing for recertification.
Key Features:
Cover Title Copyright Contents Contributors Preface Share Hematology Board Review: Blueprint Study Guide and Q&A Chapter 1: Normal Hematopoiesis Developmental Hematopoiesis Hematopoietic Stem Cells Hematopoietic Microenvironment Assessment of Hematopoiesis Questions Answers Chapter 2: Red Blood Cell Production Disorders Nutritional Deficiencies Epidemiology Etiology and Risk Factors Signs and Symptoms Diagnostic Workup/Criteria Treatment Anemia of Chronic Disease Epidemiology Etiology and Risk Factors Signs and Symptoms Diagnostic Workup/Criteria Treatment Red Cell Aplasia Epidemiology Etiology and Risk Factors Pathology—Classification Signs and Symptoms Diagnostic Workup/Criteria Prognosis Treatment Sideroblastic Anemia Epidemiology Etiology and Risk Factors Signs and Symptoms Diagnostic Workup/Criteria Prognostic Factors Treatment Congenital Dyserythropoietic Anemias (CDA) Epidemiology Etiology and Risk Factors Signs and Symptoms Diagnostic Workup Treatment Inefficient Erythropoiesis in Thalassemias Definition Etiology Signs and Symptoms Diagnostic Workup Treatment Questions Answers Chapter 3: Red Cell Destruction Disorders Warm Antibody Hemolytic Anemia Epidemiology Etiology and Risk Factors Signs and Symptoms Diagnostic Criteria Treatment Cold Agglutinin Disease (CAD) Epidemiology Staging Diagnostic Criteria Treatment Paroxysmal Nocturnal Hemoglobinuria Epidemiology Etiology and Risk Factors Signs and Symptoms Diagnostic Criteria Staging Prognostic Factors Treatment Paroxysmal Cold Hemoglobinuria Epidemiology Treatment Metabolic Enzyme Deficiency Hemolytic Anemia Glucose 6 Phosphate Dehydrogenase Deficiency Treatment Pyruvate Kinase Deficiency Diagnostic Criteria Signs and Symptoms Treatment Pyrimidine 5\' Nucleotidase (p5\'n-1) Deficiency Red Cell Membrane Defects Hereditary Spherocytosis Diagnostic Criteria Signs and Symptoms Treatment Other Red Cell Membrane Defects Questions Answers Chapter 4: The Sickle Cell Syndromes Definitions and Nomenclature Demographics Pathophysiology The Sickle Cell Syndromes Diagnosis Caveats in the Clinical Presentation of the Various Sickle Cell Syndromes Management of Acute Episodes Management of Acute Chest Syndrome Management of Vaso-occlusive Pain Crisis Preventive Care in SCD Transfusions in Sickle Cell Disease Iron Overload in SCD Advanced Therapies in SCD Questions Answers Chapter 5: White Blood Cell Disorders Granulocyte Disorders Neutrophil Overview Acquired Neutrophil Disorders Inherited Neutrophil Disorders Treatment of Neutropenia Monocyte Overview Causes of Monocytosis and Monocytopenia Eosinophil Overview Causes of Eosinophilia and Eosinopenia Basophil Overview Causes of Basophilia and Basophilopenia Lymphocyte Disorders Causes of Lymphopenia and Lymphocytosis Questions Answers Chapter 6: Bone Marrow Failure/Aplastic Anemia Bone Marrow Failure/Aplastic Anemia Definition Epidemiology Diagnostic Criteria Staging Signs and Symptoms Prognostic Factors Treatment Questions Answers Chapter 7: Platelet and Megakaryocyte Disorders Megakaryocyte and Platelet Overview Laboratory Evaluation of Platelets Platelet Disorders Questions Answers Chapter 8: Hemostasis Molecular Basis of Coagulation Laboratory Evaluation Hereditary Bleeding/Vascular Disorders Acquired Bleeding Disorders Hemostatic Drugs Questions Answers Chapter 9: Thrombosis Hereditary Thrombophilias Acquired Thrombotic Disorders Thrombosis Management Thrombosis Complications Laboratory Testing and Imaging Antiplatelet and Anticoagulant Drugs Questions Answers Chapter 10: Myeloproliferative Neoplasms Chronic Myelogenous Leukemia (CML) Epidemiology Etiology and Risk Factors Diagnostic Criteria Staging Signs and Symptoms Prognostic Factors Treatment Myeloproliferative Neoplasms (General) Polycythemia Vera Epidemiology Diagnostic Criteria Signs and Symptoms Treatment Essential Thrombocythemia Epidemiology Diagnostic Criteria Signs and Symptoms Treatment Primary Myelofibrosis Epidemiology Diagnostic Criteria Signs and Symptoms Prognostic Factors Treatment Questions Answers Chapter 11: Acute Leukemia Acute Myeloid Leukemia Epidemiology Etiology and Risk Factors Pathology—Classification Signs and Symptoms Diagnostic Workup Prognostic Factors Treatment Acute Lymphoblastic Leukemia (ALL) Epidemiology Etiology and Risk Factors Pathology—Classification Signs and Symptoms Diagnostic Workup Prognostic Factors Treatment Questions Answers Chapter 12: Myelodysplastic Syndromes Mylodysplastic Syndromes Definition Epidemiology Etiology, Risk Factors, and Pathogenesis Signs and Symptoms Diagnosis Classification Prognostic Factors Indications for Treatment Treatment Chronic Myelomonocytic Leukemia Questions Answers Chapter 13: Non-Hodgkin Lymphoma—High Grade Epidemiology Staging Diagnosis Diffuse Large B-Cell Lymphoma (DLBCL) Epidemiology Pathology and Staging Prognostic Factors Treatment Special Considerations Burkitt Lymphoma (BL) Epidemiology Presentation Pathology and Staging Prognosis Treatment Mantle Cell Lymphoma (MCL) Epidemiology Presentation Pathology and Staging Prognostic Factors Treatment Questions Answers Chapter 14: Non-Hodgkin Lymphoma—Low Grade Epidemiology Etiology and Risk Factors Staging Signs and Symptoms Diagnostic Features Lymphoplasmacytic Lymphoma/Waldenström’s Macroglobulinemia Signs and Symptoms Diagnosis Treatment Chronic Lymphocytic Leukemias Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia Diagnosis Staging Treatment Prognosis Monoclonal B-Cell Lymphocytosis Hairy Cell Leukemia Treatment Follicular Lymphoma Grade and Prognostic Factors Treatment Marginal Zone Lymphoma Signs and Symptoms Treatment Questions Answers Chapter 15: Multiple Myeloma and Plasma Cell Dyscrasias Epidemiology Etiology and Risk Factors Screening and Diagnostic Criteria Pathology Signs and Symptoms Risk Stratification Staging Treatment Questions Answers Chapter 16: Immunodeficiency-Associated Lymphoproliferative Disorders Immunodeficiency-Associated Lymphoproliferative Disorders Definition Posttransplant Lymphoproliferative Disorders Epidemiology Etiology and Risk Factors Classification Signs and Symptoms Diagnosis Treatment AIDS-Related Lymphoma Definition Epidemiology Etiology and Risk Factors Classification Signs and Symptoms Staging Diagnosis Treatment Iatrogenic Immunodeficiency Lymphoproliferative Disorders in Nontransplant Settings Definition Etiology Epidemiology and Risk Factors Pathology Treatment Questions Answers Chapter 17: T-Cell and NK-Cell Neoplasms Epidemiology Risk Factors Signs and Symptoms Staging Pathology Prognostic Factors Treatment Special Considerations Questions Answers Chapter 18: Hodgkin Lymphoma Definition/Classification Epidemiology Etiology and Risk Factors Staging Signs and Symptoms Diagnostic Criteria Indications for Treatment Prognostic Factors Treatment Special Considerations Questions Answers Chapter 19: Other Neoplasms (Histiocytic and Dendritic Cell Neoplasms, Myeloid and Lymphoid Neoplasms With Eosinophilia) Histiocytic Disorders Dendritic Cell Neoplasms Myeloid and Lymphoid Neoplasms With Eosinophilia Questions Answers Chapter 20: Hematologic Emergencies and Supportive Care Hematologic Emergencies Tumor Lysis Syndrome Hyperleukocytosis and Leukostasis Urgent/emergent Management of Acute Leukemia Febrile Neutropenia Chemotherapy Extravasation Supportive Care Antimicrobial Prophylaxis Chemotherapy-Induced Nausea and Vomiting Cancer-Associated Venous Thromboembolic Disease Pain Management Cancer Cachexia Dyspnea Psychiatric Syndromes Questions Answers Chapter 21: Transfusion Medicine Blood Products and Transfusion Diagnostic Criteria Signs and Symptoms Risks Associated With Transfusion of Blood Products Apheresis Risks Associated With Therapeutic Apheresis Procedures Questions Answers Chapter 22: Stem Cell Biology and Hematopoiesis Questions Answers Chapter 23: Hematopoietic Cell Transplant In the Management of Hematologic Disease Questions Answers Chapter 24: Complications After Hematopoietic Cell Transplantation Marrow Engraftment Failure Graft Versus Host Disease (GVHD) Opportunistic Infections Hepatic Sinusoidal Obstruction Syndrome Management of Relapse Late Effects Questions Answers Chapter 25: Biostatistics Basic Concepts and Definitions Diagnostic Tests Clinical Trials Study Biases Questions Answers Index